# Molnupiravir \(EIDD-2801/MK-4482\) Supply Agreement for Pandemic Purposes

> Contract award record from UK public-sector procurement sources.

## Key facts

- Public buyer: [Department of Health and Social Care](/buyers/department-of-health-and-social-care/contract-awards)
- Contract winner: Merck Sharpe & Dohme \(UK\) Limited
- Award value: £1
- Tender value: £1
- Award date: 13 October 2021
- Published: 18 November 2021
- Contract start: 13 October 2021
- Contract end: 31 December 2022
- Stage: awarded
- Procurement category: goods
- Notice ID: cd40a4e6-f80b-4a30-986b-7bba753e2710-486698
- OCID: ocds-b5fd17-9fe3853b-4529-4429-8108-e546f9e7c575

## Description

Vaccines have been shown to be highly effective in the fight against COVID-19, to date\. However, there is a cohort of individuals who either cannot take the vaccine or for whom it is ineffective\. There is therefore an urgent need to find an effective alternative\. So far there are no primary care antiviral drugs that can be easily dispensed specifically to treat SARS-CoV-2 and prevent its transmission in the community\. This agreement is for the procurement of 480,000 units of Molnupiravir \(EIDD-2801/MK-4482\)\. It is one of the first oral and direct-acting antiviral drugs globally and the first to receive regulatory approval and is part of the UK's multi-layered approach to COVID-19\.

## Related contract awards

- [Internet Resilience](/contracts/ocds-b5fd17-8924db22-54d2-4f5f-96a4-8e39e5d358da): Department of Health and Social Care
- [DHSC: CAG: Contingent Labour for PPE Contract Dissolution Programme 2026/27](/contracts/ocds-b5fd17-10d42cb8-fc29-4255-ba0c-cac9302e2898): Department of Health and Social Care
- [DHSC: Analytical Support for Priority Programmes \(Extension\)](/contracts/ocds-b5fd17-d8e92016-565a-4783-bebd-e36253804bf2): Department of Health and Social Care
- [Human Papillomavirus \(2025\)](/contracts/ocds-b5fd17-68eba892-08bc-4cf4-b8b4-34aef5a483d4): UK Health Security Agency
- [Measles, Mumps, Rubella and Varicella \(MMRV\) vaccine \(2025\)](/contracts/ocds-b5fd17-427ee398-bfdc-4b3a-8b1e-5b03ad89b555): UK Health Security Agency
- [NHS Framework Agreement for London, Branded Medicines - Tranche A and Annual](/contracts/ocds-b5fd17-48a46094-6452-4cc9-a07d-02aa12ec6831): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/cd40a4e6-f80b-4a30-986b-7bba753e2710-486698)